Navigation Links
Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon

New York, New York (PRWEB) December 26, 2012

The runaway biotech bestseller, WIRED, was not only a New York Times and USA Today bestseller, but the bestselling Kindle novel of 2011 in two major categories—science fiction and technothrillers—an unprecedented achievement.

Now, as the WIRED sequel, AMPED, climbs the charts to glowing reviews, the eBook version of WIRED has regained the top spot on Amazon's technothriller list, and is being offered on Amazon for only $5.95. The author of these books, Douglas E. Richards, has been frequently compared to the late Michael Crichton for his ability to weave action, suspense, and well-researched science into riveting page-turners.

Richards has a master's degree in genetic engineering and was a biotechnology executive for many years. "When I wrote WIRED," he explains, "I asked myself the question: what if it were possible to boost human IQ to immeasurable levels for short periods of time? What capabilities might this confer? What changes to attitude and personality? Would this bring out our better angels or unleash our darker sides, causing us to grow ever more drunk with power?"

Both WIRED and AMPED answer these questions in a way that bestselling author Boyd Morrison calls, "action-packed, breathtaking, and mind-blowing."

According to SFRevu founder, Ernest Lilley, "WIRED has a twisty plot, big ideas, and nonstop action and intrigue. It'll have you guessing until the very end."

To learn more about Richards and his work, visit his website at or Friend him on Facebook at Douglas E. Richards Author.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
2. UMBC Expands Offerings at The Universities at Shady Grove with Biotechnology Graduate Program
3. Bar Harbor BioTechnology to Offer Direct Sales Starting in 2013; Development of StellARrays™ for C.elegans and Zebrafish Underway
4. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
5. Global Agricultural Biotechnology Industry
6. Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
7. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
8. David Lichtenstein: Biotechnology is Rich Area for Investment
9. Germany Prioritizes Medical Biotechnology with New Initiatives
10. Biomass characterization technology research highlighted in Industrial Biotechnology journal
11. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
Post Your Comments:
(Date:11/25/2015)... 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced  today ... rights plan (Rights Plan) in an effort to preserve ... under Section 382 of the Internal Revenue Code (Code). ... use of its NOLs could be substantially limited if ... Section 382 of the Code. In general, an ownership ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... Muncie, IN (PRWEB) , ... November 25, 2015 ... ... Aeronautics (AMA) and the Organization of Black Aerospace Professionals (OPBAP) has been formalized ... Mathewson and other AMA team leaders met with OPBAP leaders Capt. Karl Minter ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):